Sofinnova adds two AI health companies to portfolio after $200m fund close
Sofinnova has invested in Deepc, Kiro, and BioCorteX, as well as recent portfolio additions Betteromics and L’école AI. Image credit: Shutterstock/Peshkova. Sofinnova Partners has closed its Digital Medicine I fund at $200m, with the venture capital (VC) firm investing in five companies through the strategy. The two most recent additions to Sofinnova’s portfolio were artificial […]
Cordance Medical wins FDA breakthrough designation for BBB-opening device
The blood brain barrier prevents many macromolecules from entering the brain. Image credit: GettyImages/Ed Reschke. The US Food and Drug Administration (FDA) has granted Cordance Medical’s NeuroAccess device with breakthrough designation status. The US-based company will now be in line for prioritised review for the device’s submission and will also be able to interact quickly […]
Aspen introduces fully integrated trauma spinal support system
The VRTX System is intended for post-operative and trauma care. Credit: Aspen Medical Products / PRNewswire. Aspen Medical Products has introduced the fully integrated trauma spinal support device, the VRTX System, for post-operative and trauma care. The VRTX System is claimed to be the first cervical to sacrum system designed to transform spinal care in […]
How global changes in reimbursement are affecting digital therapeutics
Digital therapeutics (DTx) are emerging as a promising healthcare innovation, offering new avenues for the prevention and treatment of various medical conditions. These software-based interventions harness the power of technology to deliver evidence-based treatments, monitor patient progress and improve health outcomes. However, a potentially major barrier to the widespread use of digital therapeutics is the […]
Thermo Fisher’s Q3 2023 revenue drops by 1%
Thermo Fisher’s net income reached $1.69bn in the quarter. Credit: Thermo Fisher Scientific. Thermo Fisher Scientific has reported a 1% decrease in revenue in the third quarter (Q3) of 2023 to $10.57bn, compared to $10.68bn in the same period last year. The company’s organic revenue was 3% lower and core organic revenue growth was 1%. […]
Elixir meets primary endpoint for novel coronary device
Elixir claim that the device is the first of its kind that releases three types of drugs. Credit: KATERYNA KON/SCIENCE PHOTO LIBRARY via Getty Images. Elixir Medical’s triple drug-eluting coronary implant has met the primary safety and efficacy endpoints in the DESyne BDS Plus Randomised Controlled Trial (RCT). The data was presented at the Transcatheter […]
Planatome secures $5m from latest investment round
Planatome’s surgical tools are currently approved for use in the US and South Korea. Credit: Peter Porrini/Shutterstock. US-based surgical equipment provider Planatome has closed its latest Series A funding round at $5m. This news follows an additional commitment of $1m in convertible venture debt, bringing the total funds raised to $6m. Planatome will use the funds […]
Roche, Ibex and Amazon partner for AI-enabled digital pathology solutions
Digital pathology technology can improve workflows and increase efficacy for laboratory pathology. Image Credit: Komsan Loonprom / Shutterstock. Roche, Ibex Medical Analytics and Amazon Web Services (AWS) have partnered to enable pathology laboratories to access Ibex’s AI-powered decision support tools to aid in the diagnosis of breast and prostate cancer through Roche’s navify Digital Pathology […]
Diadem, Quest Diagnostics partner for AlzoSure Predict in US
AlzoSure Predict uses an antibody (U-p53AZ) for measuring blood levels of a conformational variant of the p53 protein. Credit: Diadem srl / PRNewswire. Diadem and Quest Diagnostics have signed an exclusive US licensing agreement for the former’s AlzoSure Predict Alzheimer’s Disease (AD) prognostic technology. Quest has obtained exclusive rights to the intellectual property of the […]
Signal: Illumina’s Grail troubles continue as Carl Icahn sues over deal
Carl Icahn speaking at a New York Times panel discussion, 2015. Photo: Neilson Barnard/Getty Images for New York Times. Illumina, the sequencing and diagnostics giant, is facing a class-action lawsuit led by activist investor Carl Icahn over its attempted acquisition of Grail, a biotech company it spun out in 2016. The company has been in […]